2 Polen Capital Bio-Techne Trades
Polen Capital's position in Bio-Techne is currently worth $2.86 Million. That's 0.01% of their equity portfolio (77th largest holding). The stake costed the investor $2.52 Million, netting the investor a gain of 13% so far.
News about Bio-Techne Corp and Polen Capital
Multiple Headwinds Dragged Bio-Techne Corp. (TECH) in Q1
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be down...
What Makes Bio-Techne Corporation (TECH) an Investment Bet?
Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth Strategy” fourth-quarter 2023 investor letter. A copy of the sa...
Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by SRS Capital Advisors Inc.
… of Bio-Techne Co. (NASDAQ: TECH – Get Rating) by 305.6% … . Analysts Set New Price Targets TECH has been the subject of … 4.04. Bio-Techne (NASDAQ: TECH – ...
BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
MINNEAPOLIS, May 12, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial...